Join us for an insightful webinar where leading experts in endocrinology and diabetes education delve into the transformative potential of GLP1-RA therapy in managing weight among individuals with Type 2 Diabetes Mellitus (T2DM).
The webinar will have live translation in Japanese and Korean.
Date: 13 May 2024
Time: 09:00 CET
Agenda
- Welcome & Introductions
- Transformative Potential of GLP1-RA in Weight Management
- Patient Perspectives and Shared Decision-Making
- Q&A Session with all panelists
- Closing Remarks
Learning Objectives
- Understand the transformative potential of GLP1-RA (Glucagon-Like Peptide-1 Receptor Agonists) in weight management for patients with Type 2 Diabetes Mellitus (T2DM).
- Gain insights into the mechanisms of action and clinical evidence supporting the use of GLP1-RA as a game-changer in weight control within the context of T2DM treatment.
- Explore the importance of patient perspectives and shared decision-making in optimizing treatment outcomes with GLP1-RA therapy.
- Engage in a collaborative Q&A session with expert panelists to address specific queries, challenges, and considerations related to GLP1-RA therapy and weight management in T2DM.
This educational activity is intended for an international audience of non-US and non-UK HCPs.
Faculty
Dr. Swapnil Khare, Inpatient Diabetes Medical Director·Indiana University Health Adult Academic Health Center
Dr. Khare believes that endocrinology is the most exciting and remarkable field of medicine. She enjoys the opportunity it brings for her to develop lasting relationships with her patients. Her clinical philosophy is to provide high-quality patient care, where the patient is in control of his or her own plan. Her clinical interests include diabetes, thyroid, adrenal and general endocrinology. Dr. Khare received her medical degree from Gandhi Medical College in Bhopal, India. She completed her internal medicine residency at St. Luke’s University Hospital in Bethlehem, Pennsylvania, as well as a fellowship in endocrinology, diabetes and metabolism at Temple University in Philadelphia, Pennsylvania. Dr. Khare is certified by the American Board of Internal Medicine. Dr. Khare is the Inpatient Diabetes Medical Director at the Indiana University Health Adult Academic Health Center.
Dr. Santosh Ramakrishnan, DM – Endocrinology, MD – General Medicine, MBBS
Dr. Santosh did his schooling and junior college in the Prestigious St Vincent’s High School Pune, MBBS: BJMC Pune, MD Internal Medicine: JIPMER Pondicherry, DM Endocrinology: PGI Chandigarh. He worked as a Consultant Endocrinologist at Apollo Hospitals in Jubilee Hills, Hyderabad for 3 Years. He then Founded Magna Clinics for Obesity Diabetes and Endocrinology, and is the Chief Endocrinologist at Hyderabad Units. He has conferred a honorary fellowship of the american college of Endocrinology – FACE. This is a Fellowship given to distinguished endocrinologists globally by the American Academy of clinical endocrinologists. Over 11 years he has seen more than 25000 patients with various endocrine disorders.